Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Potential role of Thiocolchicoside in anxiety disorder: A pre-clinical study

View through CrossRef
Abstract Aim :The aim of the current study is to evaluate anti-anxiety and potentiating effect of Thiocolchicoside in animal models of anxiety. Methodology: A total of 24 (n=24) Swiss albino mice were procured, and they were divided into four groups of six mice in each. First group of mice (control) received 10 ml/kg-Normal Saline, second group (standard) received 2.0 mg/kg-Diazepam, test-1 received 1 mg/kg-Thiocolchicoside and test-2 received Thiocolchicoside (1mg/kg) + Diazepam (2mg/kg) for seven days per orally. All the mice were evaluated for anti-anxiety activity by Elevated Plus Maze (EPM) 60 minutes after the oral drug administration of drugs on day 1, 3 and 7 and later after a washout period of one month, same four groups of mice were screened by Light and Dark Arena (LDA) model after receiving respective drugs. Results: One-way ANOVA followed by Tukey’s Kramer test were applied for inter group comparison and correlation test for intra-group comparison. Results are expressed in mean ± SEM. In EPM, time spent in open arm for the control, standard, test- 1 and test-2 were 64.5±25.81, 128.33±17.6, 138±10.56 and 168.33±22.35 seconds respectively. There is statistically significant difference between standard (P=0.05), test-1 (P=0.05) and test-2 (P=0.03) when compared with control group. Similarly, time spent in closed arm for the control, standard, test-1 and test-2 were 238.83±20.41, 171.67± 17.6, 162±10.56 and 131.67±22.35 seconds respectively. In this, test-2 is statistically significant from the control group (P=0.05). The number of entries in the open arm for the control group, standard group, test-1 and test-2 were 3.5±1.64, 13.17±7.44, 21 ± 4.05 and 13.33 ± 2.16 respectively. There is statistically significant difference between standard (P=0.03), test-1 (P=0.02) and test-2 (P=0.03) with control. Similarly, number of entries to closed arm for the control, standard, test-1 and test-2 were 9.5±3.62, 16.33 ± 5.65, 16.33 ± 4.23 and 8.17 ± 1.72 respectively. The values obtained for the standard, test-1 and test-2 were not statistically significant (P=0.8). In LDA, time spent in light arena for the control, standard, test-1 and test-2 were 106.83±18.21, 163.5±21.66, 105.33 ± 11.57 and 125.17 ± 16.35 seconds respectively. Statistically significant difference between the control and the standard group (P=0.05) is noted. Time spent in dark arena for the control, standard, test-1 and test-2 were 193.17±18.21, 136.5±11.66, 194.67±15.57 and 174.83±16.35 seconds respectively. Here only standard group is statistically significant when compared with control (P=0.05). The number of entries in the light arena for the control, standard, test-1 and test-2 were 11.67 ± 1.37, 13.17 ± 2.48, 12 ± 2.61 and 11.67 ± 1.03 respectively. The number of entries in the dark arena for the control, standard, test-1 and test-2 were 12.17 ± 1.47, 13.17 ± 2.93, 11.83 ± 2.23 and 11 ± 0.89 respectively. With regard to number of entries in the light and dark arena there was no statistical significant difference between the groups (P>0.05). Conclusion: The study result clearly showed that Thiocolchicoside (1 mg/kg) has anti anxiety and additional potentiating effect when combined with diazepam in EPM and LDA models.
Title: Potential role of Thiocolchicoside in anxiety disorder: A pre-clinical study
Description:
Abstract Aim :The aim of the current study is to evaluate anti-anxiety and potentiating effect of Thiocolchicoside in animal models of anxiety.
Methodology: A total of 24 (n=24) Swiss albino mice were procured, and they were divided into four groups of six mice in each.
First group of mice (control) received 10 ml/kg-Normal Saline, second group (standard) received 2.
0 mg/kg-Diazepam, test-1 received 1 mg/kg-Thiocolchicoside and test-2 received Thiocolchicoside (1mg/kg) + Diazepam (2mg/kg) for seven days per orally.
All the mice were evaluated for anti-anxiety activity by Elevated Plus Maze (EPM) 60 minutes after the oral drug administration of drugs on day 1, 3 and 7 and later after a washout period of one month, same four groups of mice were screened by Light and Dark Arena (LDA) model after receiving respective drugs.
Results: One-way ANOVA followed by Tukey’s Kramer test were applied for inter group comparison and correlation test for intra-group comparison.
Results are expressed in mean ± SEM.
In EPM, time spent in open arm for the control, standard, test- 1 and test-2 were 64.
5±25.
81, 128.
33±17.
6, 138±10.
56 and 168.
33±22.
35 seconds respectively.
There is statistically significant difference between standard (P=0.
05), test-1 (P=0.
05) and test-2 (P=0.
03) when compared with control group.
Similarly, time spent in closed arm for the control, standard, test-1 and test-2 were 238.
83±20.
41, 171.
67± 17.
6, 162±10.
56 and 131.
67±22.
35 seconds respectively.
In this, test-2 is statistically significant from the control group (P=0.
05).
The number of entries in the open arm for the control group, standard group, test-1 and test-2 were 3.
5±1.
64, 13.
17±7.
44, 21 ± 4.
05 and 13.
33 ± 2.
16 respectively.
There is statistically significant difference between standard (P=0.
03), test-1 (P=0.
02) and test-2 (P=0.
03) with control.
Similarly, number of entries to closed arm for the control, standard, test-1 and test-2 were 9.
5±3.
62, 16.
33 ± 5.
65, 16.
33 ± 4.
23 and 8.
17 ± 1.
72 respectively.
The values obtained for the standard, test-1 and test-2 were not statistically significant (P=0.
8).
In LDA, time spent in light arena for the control, standard, test-1 and test-2 were 106.
83±18.
21, 163.
5±21.
66, 105.
33 ± 11.
57 and 125.
17 ± 16.
35 seconds respectively.
Statistically significant difference between the control and the standard group (P=0.
05) is noted.
Time spent in dark arena for the control, standard, test-1 and test-2 were 193.
17±18.
21, 136.
5±11.
66, 194.
67±15.
57 and 174.
83±16.
35 seconds respectively.
Here only standard group is statistically significant when compared with control (P=0.
05).
The number of entries in the light arena for the control, standard, test-1 and test-2 were 11.
67 ± 1.
37, 13.
17 ± 2.
48, 12 ± 2.
61 and 11.
67 ± 1.
03 respectively.
The number of entries in the dark arena for the control, standard, test-1 and test-2 were 12.
17 ± 1.
47, 13.
17 ± 2.
93, 11.
83 ± 2.
23 and 11 ± 0.
89 respectively.
With regard to number of entries in the light and dark arena there was no statistical significant difference between the groups (P>0.
05).
Conclusion: The study result clearly showed that Thiocolchicoside (1 mg/kg) has anti anxiety and additional potentiating effect when combined with diazepam in EPM and LDA models.

Related Results

A comparative study of the efficacy and safety of thiocolchicoside and chlorzoxazone in patients with acute musculoskeletal pain
A comparative study of the efficacy and safety of thiocolchicoside and chlorzoxazone in patients with acute musculoskeletal pain
Background: Thiocolchicoside and chlorzoxazone are commonly used muscle relaxants for the management of acute musculoskeletal pain. However, there is limited evidence comparing the...
A comparative study of the efficacy and safety of thiocolchicoside and chlorzoxazone in patients with acute musculoskeletal pain
A comparative study of the efficacy and safety of thiocolchicoside and chlorzoxazone in patients with acute musculoskeletal pain
Background: Thiocolchicoside and chlorzoxazone are commonly used muscle relaxants for the management of acute musculoskeletal pain. However, there is limited evidence comparing the...
Preformulation characterization of Thiocolchicoside
Preformulation characterization of Thiocolchicoside
Introduction: Thiocolchicoside is semi-synthetic sulfur derivative of colchicine, which is a naturally occurring glucoside in the Colchicine plant. It is potent muscle relaxant wit...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Development of the Ego and Discomfort Anxiety Inventory: Initial Validity and Reliability
Development of the Ego and Discomfort Anxiety Inventory: Initial Validity and Reliability
This article reports on four studies regarding the development, reliability, and validity of scales to measure two forms of anxiety, ego anxiety and discomfort anxiety. In the firs...
RP HPLC Method Development for Simultaneous Estimation of Etoricoxib and Thiocolchicoside
RP HPLC Method Development for Simultaneous Estimation of Etoricoxib and Thiocolchicoside
A simple, specific and accurate reverse phase high performance liquid chromatography (RP-HPLC) method was developed and validated for simultaneous estimation of Etoricoxib and Thio...
Major depressive disorder and generalized anxiety disorder and response to treatment in hepatitis C patients in Egypt
Major depressive disorder and generalized anxiety disorder and response to treatment in hepatitis C patients in Egypt
Objectives The aim of the study was to estimate the prevalence and associated correlates of major depressive disorder and generalized anxiety disorder in hepati...
Generalized Anxiety and Political Participation
Generalized Anxiety and Political Participation
<p>News media relies on widespread discussion of anxiety and emotions to describe the environment of presidential elections. Previous academic literature has sought to captur...

Back to Top